United States · Financial press · Investor's Business Daily
Charles River Labs, A Top 2% Medical Stock, Drops Despite Its Beat And Raise
Charles River Laboratories stock fell early Wednesday, though the medical research firm beat third-quarter forecasts and raised guidance. The post Charles River Labs, A Top 2%…
Read the full article on Investor's Business Daily Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investors.com)